Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-26 @ 4:14 AM
Study NCT ID:
NCT05656027
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2022-12-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
Sponsor:
LENZ Therapeutics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-09
First Submit QC Date:
None
Study First Post Date:
2022-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-01-31
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-12-13
Last Update Post Date:
2024-12-18
Last Update Post Date Type:
ACTUAL